ConductScience.org, home

Paper20135207

Model analysis of the concentration-dependent permeability of P-gp substrates.

Tachibana T and 6 others. Pharm Res, 2010. Cited by 86 papers, by iCite.

Cite this record

ConductScience Library. Model analysis of the concentration-dependent permeability of P-gp substrates. Papers, record 20135207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20135207

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Model analysis of the concentration-dependent permeability of P-gp substrates.
PubMed
Journal
Pharm Res
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
3.11
iCite
Revised in PubMed
2021-10-20
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tachibana TTatsuhiko
2Kitamura SSatoshi
3Kato MMotohiro
4Mitsui TTetsuya
5Shirasaka YYoshiyuki
6Yamashita SShinji
7Sugiyama YYuichi

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ATP Binding Cassette Transporter, Subfamily B, Member 1Major topic
QuinidineMajor topic
VerapamilMajor topic
VinblastineMajor topic
Animals
Biological Transport
Caco-2 Cells
Gene Expression
Humans
Models, Biological

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112047481Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.Br J Clin Pharmacol2002https://conductscience.org/library/papers/12047481PubMed
212134945Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?Pharm Res2002https://conductscience.org/library/papers/12134945PubMed
318276834Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.Drug Metab Dispos2008https://conductscience.org/library/papers/18276834PubMed
412608532Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.Pharm Res2003https://conductscience.org/library/papers/12608532PubMed
58710739Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo.Pharm Res1996https://conductscience.org/library/papers/8710739PubMed
610706193P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.Int J Clin Pharmacol Ther2000https://conductscience.org/library/papers/10706193PubMed
712869659Impact of drug transporter studies on drug discovery and development.Pharmacol Rev2003https://conductscience.org/library/papers/12869659PubMed
811990778Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo.Novartis Found Symp2002https://conductscience.org/library/papers/11990778PubMed
92864056Celiprolol: pharmacokinetics and duration of pharmacodynamic activity.Br J Clin Pract Suppl1985https://conductscience.org/library/papers/2864056PubMed
1011327196The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.Clin Pharmacokinet2001https://conductscience.org/library/papers/11327196PubMed
1115276711Importance of P-glycoprotein at blood-tissue barriers.Trends Pharmacol Sci2004https://conductscience.org/library/papers/15276711PubMed
1217828734Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane.J Pharm Sci2008https://conductscience.org/library/papers/17828734PubMed
1317548462Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates.Drug Metab Dispos2007https://conductscience.org/library/papers/17548462PubMed
1414641550Importance of P-glycoprotein for drug disposition in humans.Eur J Clin Invest2003https://conductscience.org/library/papers/14641550PubMed
151979923Pharmacokinetics of pafenolol after i.v. and oral administration of three separate doses of different strength to man.Biopharm Drug Dispos1990https://conductscience.org/library/papers/1979923PubMed

Download CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
41735693
Quantitative Analysis of the Effect of Gastrointestinal Water Dynamics on Oral Drug Absorption using a Physiologically Based Integrated Liquid and Intestinal Absorption Drug (ILIAD) Pharmacokinetic Model.
Pharm Res2026https://conductscience.org/library/papers/41735693PubMed
41731530Evaluating sex as a biological variable in in vitro blood-brain barrier models: insights from primary mouse brain endothelial cells.Fluids Barriers CNS2026https://conductscience.org/library/papers/41731530PubMed
41629699Simulation-based assessment of the P-glycoprotein expression-activity relationship shows a drug and system dependency.J Pharmacokinet Pharmacodyn2026https://conductscience.org/library/papers/41629699PubMed
41304794Classifying Effluxable Versus Non-Effluxable Compounds Using a Permeability Threshold Based on Fundamental Energy Constraints.Pharmaceutics2025https://conductscience.org/library/papers/41304794PubMed
39921770Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?J Pharmacokinet Pharmacodyn2025https://conductscience.org/library/papers/39921770PubMed
39838673Network Pharmacology, Molecular Docking, Molecular Dynamics to Explore the Mechanism of Danggui Shaoyao Powder for Hepatic Encephalopathy.Curr Pharm Des2025https://conductscience.org/library/papers/39838673PubMed
39542928Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms.Arch Toxicol2025https://conductscience.org/library/papers/39542928PubMed
37283406Interlaboratory Variability in the Madin-Darby Canine Kidney Cell Proteome.Mol Pharm2023https://conductscience.org/library/papers/37283406PubMed
37101392Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution.CPT Pharmacometrics Syst Pharmacol2023https://conductscience.org/library/papers/37101392PubMed
36541850The Rat Continuous Intestine Model Predicts the Impact of Particle Size and Transporters on the Oral Absorption of Glyburide.Mol Pharm2023https://conductscience.org/library/papers/36541850PubMed
35501528A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.AAPS J2022https://conductscience.org/library/papers/35501528PubMed
35488144
Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs.
Pharm Res2022https://conductscience.org/library/papers/35488144PubMed
35083640Limited Impact of Murine Placental MDR1 on Fetal Exposure of Certain Drugs Explained by Bypass Transfer Between Adjacent Syncytiotrophoblast Layers.Pharm Res2022https://conductscience.org/library/papers/35083640PubMed
34729944Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P-glycoprotein-cytochrome P450 3A4 dual substrates.CPT Pharmacometrics Syst Pharmacol2021https://conductscience.org/library/papers/34729944PubMed
34668334Physiologically-based pharmacokinetic modeling to evaluate in vitro-to-in vivo extrapolation for intestinal P-glycoprotein inhibition.CPT Pharmacometrics Syst Pharmacol2022https://conductscience.org/library/papers/34668334PubMed
34272714Case Study 7: Transporters Case Studies-In Vitro Solutions for Translatable Outcomes.Methods Mol Biol2021https://conductscience.org/library/papers/34272714PubMed
34272702Prediction of Drug Clearance from Enzyme and Transporter Kinetics.Methods Mol Biol2021https://conductscience.org/library/papers/34272702PubMed
34272693Consideration of the Unbound Drug Concentration in Enzyme Kinetics.Methods Mol Biol2021https://conductscience.org/library/papers/34272693PubMed
34080309Model-based assessments of CYP3A-mediated drug-drug interaction risk of milademetan.Clin Transl Sci2021https://conductscience.org/library/papers/34080309PubMed
34009624Analysis of Non-linear Pharmacokinetics of P-Glycoprotein Substrates in a Microfluidic Device Using a Mathematical Model that Includes an Unstirred Water Layer (UWL) Compartment.Pharm Res2021https://conductscience.org/library/papers/34009624PubMed

See all 40 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20135207

GET https://conductscience.org/api/papers/v1/20135207/cited_by?page=2